Interestingly, although all colon cancer-, CIMP-, and BRAF mutation-specific differentially methylated regions are underrepresented for H3K4me3, this depletion is most evident for BRAF mutation-specific regions. This evidence concerns the gene BRAF and malignant colon neoplasm.